KHIRE; Uday

Patent Applications and Registrations

Patent applications and USPTO patent grants for KHIRE; Uday.The latest application filed is for "omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitors".

Company Profile

0.19.55

KHIRE; Uday - Hamden CT
Khire; Uday - Orange CT
Khire, Uday - Handen CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Omega-carboxyarl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20140329866 - RIEDL; Bernd ; et al.	2014-11-06
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 8,841,330 - Riedl , et al. September 23, 2	2014-09-23
Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase Grant 8,338,594 - Magnuson , et al. December 25, 2	2012-12-25
Inhibition Of P38 Kinase Using Symmetrical And Unsymmetrical Diphenyl Ureas App 20120270878 - MILLER; Scott ; et al.	2012-10-25
Inhibition Of P38 Kinase Activity Using Substituted Heterocyclic Ureas App 20120149706 - DUMAS; Jacques ; et al.	2012-06-14
Omega-carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20120142742 - Riedl; Bernd ; et al.	2012-06-07
Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas App 20120129893 - DUMAS; Jacques ; et al.	2012-05-24
Stabilizing ligands for regulation of protein function Grant 8,153,785 - Khire , et al. April 10, 2	2012-04-10
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,143,393 - Dixon , et al. March 27, 2	2012-03-27
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,129,379 - Dixon , et al. March 6, 2	2012-03-06
.omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 8,124,630 - Riedl , et al. February 28, 2	2012-02-28
Inhibition Of P38 Kinase Activity Using Substituted Heterocyclic Ureas App 20120046290 - Dumas; Jacques ; et al.	2012-02-23
Omega Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20120040986 - RIEDL; Bernd ; et al.	2012-02-16
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas Grant 7,928,239 - Dumas , et al. April 19, 2	2011-04-19
Pyrrolotriazine Derivatives Useful For Treating Cancer Through Inhibition Of Aurora Kinase App 20110021518 - Magnuson; Steven ; et al.	2011-01-27
Nanoscale Molecule Synthesis App 20100291485 - Lapsys; Troy ; et al.	2010-11-18
Novel Stabilizing Ligands For Regulation of Protein Function App 20100267950 - Khire; Uday ; et al.	2010-10-21
Rho-kinase Inhibitors App 20100216789 - NAGARATHNAM; Dhanapalan ; et al.	2010-08-26
Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20100179125 - Dixon; Julie A. ; et al.	2010-07-15
Rho-kinase Inhibitors App 20100137324 - Nagarathnam; Dhanaphalan ; et al.	2010-06-03
Process For Preparing Quinazoline Rho-kinase Inhibitors And Intermediates Thereof App 20100125139 - BANKSTON; Donald ; et al.	2010-05-20
Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis App 20100063038 - Dixon; Julie ; et al.	2010-03-11
Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors Grant 7,648,986 - Nagarathnam , et al. January 19, 2	2010-01-19
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof Grant 7,645,878 - Bankston , et al. January 12, 2	2010-01-12
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Grant 7,625,915 - Dumas , et al. December 1, 2	2009-12-01
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS App 20090118268 - Riedl; Bernd ; et al.	2009-05-07
Hydroxy, .omega.-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors Grant 7,528,255 - Riedl , et al. May 5, 2	2009-05-05
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas Grant 7,517,880 - Miller , et al. April 14, 2	2009-04-14
Inhibition Of P38 Kinase Using Symmetrical And Unsymmetrical Diphenyl Ureas App 20090093526 - Miller; Scott ; et al.	2009-04-09
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas App 20080300281 - Dumas; Jacques ; et al.	2008-12-04
2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents App 20080293696 - Brennan; Catherine ; et al.	2008-11-27
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas App 20080269265 - Miller; Scott ; et al.	2008-10-30
Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas App 20080194580 - Dumas; Jacques ; et al.	2008-08-14
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20080153823 - Riedl; Bernd ; et al.	2008-06-26
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas Grant 7,371,763 - Dumas , et al. May 13, 2	2008-05-13
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20080108672 - Riedl; Bernd ; et al.	2008-05-08
.omega.-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 7,351,834 - Riedl , et al. April 1, 2	2008-04-01
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas Grant 7,329,670 - Dumas , et al. February 12, 2	2008-02-12
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors App 20080032979 - Riedl; Bernd ; et al.	2008-02-07
omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors App 20080027061 - Riedl; Bernd ; et al.	2008-01-31
Inhibition Of Raf Kinase Using Aryl And Heteroaryl Substituted Heterocyclic Ureas App 20080009527 - Dumas; Jacques ; et al.	2008-01-10
Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas App 20070244120 - Dumas; Jacques ; et al.	2007-10-18
Rho-kinase Inhibitors App 20070238741 - Nagarathnam; Dhanapalan ; et al.	2007-10-11
Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions App 20070213339 - Khire; Uday ; et al.	2007-09-13
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Grant 7,235,576 - Riedl , et al. June 26, 2	2007-06-26
Method of treating cancer with quinolone carboxylic acid derivatives App 20060142295 - Dumas; Jacques ; et al.	2006-06-29
Rho-kinase inhibitors App 20060142313 - Nagarathnam; Dhanaphalan ; et al.	2006-06-29
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas App 20060019990 - Dumas; Jacques ; et al.	2006-01-26
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20050215594 - O'Connor, Stephen J. ; et al.	2005-09-29
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,919,371 - O'Connor , et al. July 19, 2	2005-07-19
Pyrazole derivatives useful in the treatment of hyper-proliferative disorders App 20040180891 - Khire, Uday ; et al.	2004-09-16
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas App 20040102636 - Miller, Scott ; et al.	2004-05-27
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20040072828 - O'Connor, Stephen J. ; et al.	2004-04-15
Rho-kinase inhibitors App 20040014755 - Nagarathnam, Dhanapalan ; et al.	2004-01-22
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Grant 6,660,752 - O'Connor , et al. December 9, 2	2003-12-09
Process for preparing quinazoline Rho-kinase inhibitiors and intermediates thereof App 20030220357 - Bankston, Donald ; et al.	2003-11-27
Omega-carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors App 20030207872 - Riedl, Bernd ; et al.	2003-11-06
Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas App 20030207914 - Dumas, Jacques ; et al.	2003-11-06
omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20030181442 - Riedl, Bernd ; et al.	2003-09-25
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20030144278 - Riedl, Bernd ; et al.	2003-07-31
Method and/or process for preparing omega-carboxyaryl substituted diphenyl ureas as raf kinas inhibitors App 20030139605 - Riedl, Bernd ; et al.	2003-07-24
Rho-kinase inhibitors App 20030125344 - Nagarathnam, Dhanaphalan ; et al.	2003-07-03
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors App 20030105091 - Riedl, Bernd ; et al.	2003-06-05
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists App 20030078260 - O'Connor, Stephen J. ; et al.	2003-04-24
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas App 20020165394 - Dumas, Jacques ; et al.	2002-11-07
Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20020137774 - Riedl, Bernd ; et al.	2002-09-26
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors App 20020065296 - Dumas, Jacques ; et al.	2002-05-30
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010034447 - Riedl, Bernd ; et al.	2001-10-25
Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors App 20010027202 - Riedl, Bernd ; et al.	2001-10-04
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010016659 - Riedl, Bernd ; et al.	2001-08-23
Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors App 20010011135 - Riedl, Bernd ; et al.	2001-08-02
omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors App 20010011136 - Riedl, Bernd ; et al.	2001-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.